New drug approved for soft-tissue cancer

(HealthDay)—The chemotherapy drug Yondelis (trabectedin) has been approved by the U.S. Food and Drug Administration to treat certain soft-tissue sarcomas (STS) that have spread or can't be treated by surgery.

Oct 23, 2015
popularity10 comments 0

Team studies point to clinical advantages of proton therapy

The search for evidence to support the growing use of proton therapy for more cancers at Penn Medicine continues to uncover valuable findings. New data from clinical trials conducted at the Robert Proton Therapy Center demonstrate ...

Oct 19, 2015
popularity62 comments 0

A sarcoma (from the Greek sarx (σάρκα) meaning "flesh") is a cancer that arises from transformed cells of mesenchymal origin. Thus, malignant tumors made of cancerous bone, cartilage, fat, muscle, vascular, or hematopoietic tissues are, by definition, considered sarcomas. This is in contrast to a malignant tumor originating from epithelial cells, which are termed carcinoma. Sarcomas are quite rare - common malignancies, such as breast, colon, and lung cancer, are almost always carcinoma.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Higher cigarette taxes linked to fewer infant deaths

Higher taxes and prices for cigarettes are strongly associated with lower infant mortality rates in the United States, according to a new study from Vanderbilt University and the University of Michigan released Dec. 1 in ...

Researchers grow retinal nerve cells in the lab

Johns Hopkins researchers have developed a method to efficiently turn human stem cells into retinal ganglion cells, the type of nerve cells located within the retina that transmit visual signals from the eye to the brain. ...

Researchers find sleep gene linked to heart failure

Researchers at the Stanford University School of Medicine have identified a gene that, when working properly, appears to reduce the risk of heart failure and improve treatment outcomes, highlighting a possible target for ...